MicroRNAs in the cancer cell-to-cell communication: An insight into biological vehicles

Cell-to-cell communication networks have indispensable roles in coordinating various biological processes in cancer cells or altering metabolism activity in both cancer and non-cancer cells. Exosomes, migrasomes, ectosomes, apoptotic bodies, and exomeres belonging to the heterogeneous world of extra...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2022-09, Vol.153, p.113449-113449, Article 113449
Main Authors: Mansoori, Behnaz, Baradaran, Behzad, Nazari, Afsaneh, Gaballu, Fereydoon Abedi, Cho, William Chi-Shing, Mansoori, Behzad
Format: Article
Language:English
Subjects:
Angiogenesis
Cancer
Cell-to-cell communication
Extracellular miRNAs
Extracellular vesicles
Multi drug resistance
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell-to-cell communication networks have indispensable roles in coordinating various biological processes in cancer cells or altering metabolism activity in both cancer and non-cancer cells. Exosomes, migrasomes, ectosomes, apoptotic bodies, and exomeres belonging to the heterogeneous world of extracellular vesicles (EVs), which have gained significant attention in recent years due to their principal role in cell-to-cell communication, including Extracellular Circulating miRNAs (ECmiRNAs) as a rich cargo content. ECmiRNAs can be taken up by target cells to mediate heterotypic cell–interactions and facilitate recipient repression in neighboring cells. The complex of ECmiRNAs with EVs, proteins, and lipoproteins structures such as TLR, AGO protein complex, HDL, and LDL can be more effective as mediators between cancer cells. The mechanism of multidrug resistance and angiogenesis in cancer cells may be altered during special signaling of EVs-ECmiRNAs during cell-to-cell communication. Also, those complexes may serve as novel biomarkers in cancer prognostication.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2022.113449